Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device

Left Ventricular Assist Device Clinical Trial

Official title: Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device

Status Completed

Clinical Trial Summary

To evaluate the concept of dynamic pump speed optimization based on the echocardiographic assessment of aortic valve opening during cardiopulmonary exercise test.

Clinical Trial Description

Left ventricular assist devices (LVAD) are becoming a destination therapy in patients with end-stage left ventricular dysfunction. Current generation pumps operate with a fixed rotation speed without the capability of automated speed adjustment. It was shown that acceleration of the pump speed during stress test increases the maximum exercise tolerance. Periodic aortic valve opening (AVO) is used to set up an optimal resting pump speed. The study aimed to evaluate the concept of dynamic pump speed optimization based on the echocardiographic assessment of AVO during the cardiopulmonary exercise test (CPET).

Patients with implanted third-generation LVADs with hydrodynamic bearing (HVAD, Medtronic, MN, USA) are prospectively enrolled. Two CPETs are performed after resting speed optimization. The first one with maintained baseline pump speed settings, and the second one with gradually increased speed depending on live echocardiographic imaging. The sequence of tests is random. ;

Related Conditions & MeSH terms

• Left Ventricular Assist Device

• NCT number: NCT05063006
• Study type: Interventional
• Source: John Paul II Hospital, Krakow
• Status: Completed
• Phase: N/A
• Start date: February 15, 2017
• Completion date: August 4, 2020